Costa Rica never scheduled ibogaine — creating a legal environment where ibogaine treatment clinics operate openly and serve patients from countries where ibogaine remains illegal.
Ibogaine is uncontrolled in Costa Rica because the national drug law — the Ley sobre Estupefacientes, Sustancias Psicotrópicas, Drogas de Uso No Autorizado (Law No. 8204) — does not list ibogaine or any iboga alkaloid on its controlled substance schedules.
Costa Rica's scheduling framework follows the 1961 UN Single Convention on Narcotic Drugs and the 1971 Convention on Psychotropic Substances. Ibogaine is not listed in either convention. That gap means iboga-derived alkaloids fall completely outside Costa Rica's drug control regime.
This is not a loophole under active legal challenge. As of 2026, no Costa Rican legislative proposal exists to schedule ibogaine. The plant medicine industry has operated openly for more than a decade without a government move to restrict it.
Being uncontrolled means ibogaine is not a crime to possess or administer. It does not mean the government certifies clinics, licenses practitioners, or sets safety standards for treatment.
Ibogaine clinics in Costa Rica operate as private medical or wellness facilities. They are subject to general Costa Rican business regulations — not psychedelic-specific oversight. The quality and safety standards you receive depend entirely on the clinic you choose.
Costa Rica ibogaine clinics function as private residential treatment centers that combine medical supervision with ibogaine administration in a retreat-style setting. Most are located in Guanacaste, Nosara, or the San José metropolitan area.
Well-known operators include Ibogaine by David, Awaken Soul, and Clear Sky Recovery. These clinics typically employ or contract with physicians, nurses, and integration counselors. Smaller operators may offer significantly thinner medical coverage.
The general model is an intake assessment, a preparation period of one to several days, the ibogaine experience itself (12–36 hours), and a post-treatment integration phase before discharge. Most programs run 7 to 14 days in total.
The two largest groups seeking ibogaine treatment in Costa Rica are people with opioid use disorder (especially those who have not responded to methadone or buprenorphine) and veterans with treatment-resistant PTSD or traumatic brain injury.
The veterans pipeline has grown substantially since Texas passed SB 2308, which established a $50 million ibogaine research and treatment fund. Veterans interested in ibogaine sometimes travel to Costa Rica privately while state programs develop. The federal NDAA also included language directing DoD to study ibogaine — see our NDAA psychedelics provision guide for details.
Ibogaine's most serious risk is fatal cardiac arrhythmia — specifically QT interval prolongation leading to torsades de pointes, a potentially fatal rhythm disorder. Every reputable Costa Rica ibogaine clinic should require the following screening before treatment begins.
A standard Costa Rica ibogaine treatment program runs 7 to 14 days and costs between $5,000 and $15,000 USD, depending on the clinic, the length of stay, and the level of aftercare included.
Days 1–2 (Arrival and screening). Medical intake, EKG, bloodwork, and medication review. The clinic's physician evaluates results and confirms that treatment can proceed safely. If electrolyte levels are low, correction begins before any ibogaine is administered.
Days 3–4 (Preparation). Preparatory sessions focus on treatment intentions, psychological history, and practical grounding. Some clinics administer a test dose — typically 3–5 mg/kg — 24–48 hours before the full flood dose to assess individual sensitivity and metabolic response.
Day 5 (Ibogaine session). The full flood dose — typically 10–20 mg/kg of ibogaine HCl — is administered in the morning under continuous cardiac monitoring. The visionary phase lasts 4–8 hours. The full experience, including residual effects, runs 12–36 hours. Patients remain in a clinical setting throughout.
Days 6–10+ (Integration). Post-treatment integration includes rest, nutritional support, counseling, and grounding activities. Ibogaine resets often produce significant cognitive and emotional shifts that require deliberate processing. Longer programs provide more structured integration support before discharge.
A $5,000–$15,000 ibogaine program in Costa Rica is expensive — but it compares favorably to alternatives. A 30-day US inpatient addiction treatment program averages $30,000–$60,000 without insurance. Ketamine infusion series in the US typically run $2,000–$6,000 for six sessions, without residential support. The Costa Rica ibogaine price point includes accommodation, meals, medical staffing, and the treatment itself.
Costa Rica (ibogaine) and Jamaica (psilocybin mushrooms) are the two most established international destinations for legal psychedelic treatment — each operating under a different substance, a different legal mechanism, and a different risk profile.
| Feature | Costa Rica — Ibogaine | Jamaica — Psilocybin |
|---|---|---|
| Legal basis | Ibogaine not listed in national drug law (Law No. 8204) | Psilocybin mushrooms not scheduled under Dangerous Drugs Act |
| Primary substances | Ibogaine (iboga alkaloid) | Psilocybin mushrooms |
| Primary conditions treated | Opioid use disorder, PTSD, TBI, addiction | Depression, anxiety, end-of-life distress, well-being |
| Session duration | 12–36 hours (ibogaine experience itself) | 4–6 hours (psilocybin experience) |
| Typical program length | 7–14 days | 4–7 days |
| Typical cost | $5,000–$15,000 USD | $2,500–$10,000 USD |
| Medical screening required? | Yes — EKG, LFTs, metabolic panel mandatory at reputable clinics | No legal requirement; some retreats offer voluntary health forms |
| Cardiac risk level | High — documented fatal QT prolongation risk | Low — no documented fatal cardiac events from psilocybin alone |
| Government oversight of providers | None specific to ibogaine therapy | None specific to psilocybin retreats |
| US federal status of substance | Schedule I — cannot bring back | Schedule I — cannot bring back |
| US insurance coverage | None | None |
When Costa Rica ibogaine makes more sense: If the primary goal is addiction interruption — especially opioid dependence — ibogaine has the stronger evidence base for that specific indication. The single-session reset mechanism is unlike anything in the psilocybin literature. The higher medical barrier to entry is a feature, not a bug: it filters out patients for whom treatment would be dangerous.
When Jamaica psilocybin makes more sense: For depression, existential distress, or personal growth work where cardiac history is a concern, psilocybin in Jamaica offers a meaningfully lower physiological risk profile. The shorter experience duration is also more accessible for people who cannot take two weeks away from work.
See our full Jamaica psilocybin legal status guide for the parallel analysis on the mushroom side.
Evaluating a Costa Rica ibogaine clinic requires asking specific questions about medical staffing, screening protocols, and emergency preparedness — not just reading testimonials or website copy.
Ibogaine remains a Schedule I controlled substance under the US Controlled Substances Act, regardless of its legal status in Costa Rica or anywhere else.
This creates three practical limits for US patients traveling to Costa Rica. First, you cannot bring ibogaine or iboga-derived products back across the US border — doing so is a federal trafficking offense. Second, no US health insurance plan covers ibogaine treatment, including Medicare, Medicaid, and VA benefits. Third, US employment drug screens may still flag ibogaine metabolites after treatment.
Congressional movement on ibogaine is active but has not changed federal scheduling. The Texas SB 2308 program funds ibogaine research and treatment within state-controlled settings — it does not fund or recognize international travel for treatment. The Arizona HB 2871 would create a similar state-level research framework if enacted. For a current picture of where psychedelic laws are moving, use our legal status by state tool.
Moving ibogaine off Schedule I would require either a DEA rulemaking petition triggered by an FDA drug approval or an Act of Congress. The FDA has not approved any ibogaine-based drug as of 2026. Clinical trials for ibogaine in opioid use disorder are underway — including studies linked to the Stanford VA research program — but no New Drug Application has been filed.
Yes. Ibogaine is not listed as a controlled substance under Costa Rica's Ley sobre Estupefacientes (Law No. 8204). Because ibogaine and iboga alkaloids do not appear on Costa Rica's controlled substance schedules, operating an ibogaine treatment clinic is legal. However, ibogaine therapy is not regulated as a specific medical treatment, so there is no government oversight of clinic quality or safety protocols.
Costa Rican law does not legally require any specific screening. However, reputable clinics require a 12-lead EKG, a QTc interval measurement (flagging anything above 450 ms in men or 470 ms in women as a contraindication), a comprehensive metabolic panel, liver function tests (AST, ALT, bilirubin), and a cardiology clearance for any patient with a cardiac history. A medication review is also essential — SSRIs, opioids in active withdrawal, and certain other drugs create dangerous interactions with ibogaine. Patients should verify that any clinic they consider requires all of these steps before accepting them.
Ibogaine treatment in Costa Rica typically costs between $5,000 and $15,000 USD for a full program including pre-treatment preparation, the ibogaine session itself, and post-treatment integration support. A standard stay runs 7 to 14 days. This is significantly less expensive than inpatient addiction treatment programs in the United States, which often exceed $30,000 for a 30-day stay.
The primary risk of ibogaine is fatal cardiac arrhythmia. Ibogaine prolongs the QT interval on an EKG, which can trigger a life-threatening arrhythmia called torsades de pointes. This risk is why cardiac screening before treatment and continuous cardiac monitoring during the ibogaine experience are essential. Other contraindications include liver disease, a personal or family history of cardiac arrhythmia, use of SSRIs or certain other medications, and schizophrenia spectrum disorders. Deaths from ibogaine treatment have occurred at clinics that did not perform adequate cardiac screening.
No. Ibogaine is a Schedule I controlled substance under US federal law. Carrying ibogaine across the US border is a federal drug trafficking offense regardless of its legal status in Costa Rica. US health insurance does not cover ibogaine treatment. Veterans accessing ibogaine through state programs like Texas SB 2308 must use state-designated providers — traveling to Costa Rica does not qualify for that funding.
Both Costa Rica (for ibogaine) and Jamaica (for psilocybin) operate in a legal gray area where the substance is uncontrolled under national law, making retreat or clinic operations legal. The key difference is medical risk and screening. Ibogaine carries a documented risk of fatal cardiac arrhythmia, so reputable Costa Rica clinics require an EKG, bloodwork, and sometimes cardiology clearance. Jamaica psilocybin retreats require no mandatory medical screening, though some voluntary screening is offered by certain operators. The substances themselves treat different conditions — ibogaine is primarily used for opioid use disorder and PTSD, while psilocybin retreats focus on depression, anxiety, and general well-being.
Not all ibogaine clinics follow the cardiac screening protocols that make treatment safe. Our retreat finder surfaces operators that meet minimum medical safety standards — so you can compare programs with confidence before you travel.
Get Costa Rica Ibogaine: Legal Status & Clinic Industry updates
New votes, rules, court rulings, and access changes for Costa Rica Ibogaine: Legal Status & Clinic Industry — delivered when they happen.
← Back to all psychedelic laws
Suggest a tool, topic, or improvement that would make this site more useful.